{"schema_version":"secwatch.filing_event.v1","accession":"0001062993-26-002900","form_type":"8-K","ticker":"MDCX","cik":"0001997296","company_name":"Medicus Pharma Ltd.","filed_at":"2026-05-27T20:45:00+00:00","discovered_at":"2026-05-27T20:46:00.253259+00:00","generated_at":"2026-05-27T20:47:48.649387+00:00","sec_items":["1.01","2.03","3.01","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Medicus Pharma closes $22M secured notes with Streeterville; receives Nasdaq MVLS non-compliance notice","bullets":["Issued two secured promissory notes to Streeterville Capital: A-1 ($12.86M principal, net $12M) and B ($10M in DACA), maturing in 18 months.","A-1 Note carries 8.75% interest and $834K OID; B Note 5% interest. Prepayment premiums of 110-115% apply.","Proceeds support clinical development, strategic initiatives, and repayment of $2.5M YA II PN debenture.","Nasdaq notified non-compliance with $35M MVLS requirement; company has 180 days to regain compliance by Nov 16, 2026.","B Note can be exchanged for A Notes when A principal reduced by $2M; trigger events allow balance increases of 15%/5%."],"urls":{"canonical":"https://secwatch.observer/filing/0001062993-26-002900","json":"https://secwatch.observer/filing/0001062993-26-002900.json","markdown":"https://secwatch.observer/filing/0001062993-26-002900.md","text":"https://secwatch.observer/filing/0001062993-26-002900.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1997296/000106299326002900/0001062993-26-002900-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1997296/000106299326002900/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T20:47:48.649387+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c82acdec964b29c636cf58309c902970a1b95a16","claim":"Medicus Pharma Ltd. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5550(b)(1), 5550(b)(3), 5810(c)(3)(C)).","evidence_excerpt":"May 20, 2026, the Company received written notice (the \"Notice\") from the Listing Qualifications Department of the Nasdaq notifying the Company that it is not in compliance with the minimum Market Value of Listed Securit","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1997296/000106299326002900/0001062993-26-002900-index.htm","confidence":0.95}],"comparable_filings":[{"accession":"0001493152-26-025433","ticker":"SONM","company_name":"DNA X, Inc.","filed_at":"2026-05-27T20:35:28+00:00","headline":"DNA X receives Nasdaq delisting notice; issues $3.05M convertible note to insider","event_type":"regulatory","sec_items":["1.01","2.03","3.01","3.02","9.01"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 1.01, 2.03, 3.01, 9.01","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-025433","json":"https://secwatch.observer/filing/0001493152-26-025433.json","markdown":"https://secwatch.observer/filing/0001493152-26-025433.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1178697/000149315226025433/0001493152-26-025433-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1178697/000149315226025433/form8-k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"May 20, 2026, the Company received written notice (the \"Notice\") from the Listing Qualifications Department of the Nasdaq notifying the Company that it is not in compliance with the minimum Market Value of Listed Securit","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1997296/000106299326002900/0001062993-26-002900-index.htm","comparable_excerpt":"May 22, 2026, the Company received a delisting determination letter from the Staff advising the Company that unless the Company requests\na hearing before a Nasdaq Hearing Panel (the “Panel”) to appeal Nasdaq’s delisting","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315226025433/0001493152-26-025433-index.htm"}},{"accession":"0001213900-26-049432","ticker":"PFSA","company_name":"Profusa, Inc.","filed_at":"2026-04-29T23:59:59+00:00","headline":"Profusa faces Nasdaq delisting for MVPHS failure; amends debt and warrant terms","event_type":"regulatory","sec_items":["1.01","2.03","3.03","3.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 1.01, 2.03, 3.01, 9.01","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-049432","json":"https://secwatch.observer/filing/0001213900-26-049432.json","markdown":"https://secwatch.observer/filing/0001213900-26-049432.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1859807/000121390026049432/0001213900-26-049432-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1859807/000121390026049432/ea0288135-8k_profusa.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"May 20, 2026, the Company received written notice (the \"Notice\") from the Listing Qualifications Department of the Nasdaq notifying the Company that it is not in compliance with the minimum Market Value of Listed Securit","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1997296/000106299326002900/0001062993-26-002900-index.htm","comparable_excerpt":"April 28, 2026, the Company received written notification from the\nNasdaq Listing Qualifications Department (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”)\nthat the Company had not regained compliance with Na","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1859807/000121390026049432/0001213900-26-049432-index.htm"}},{"accession":"0001493152-26-025244","ticker":"XHLD","company_name":"TEN Holdings, Inc.","filed_at":"2026-05-26T20:05:22+00:00","headline":"TEN Holdings receives Nasdaq equity deficiency notice; issues 500k shares for $500k","event_type":"regulatory","sec_items":["1.01","3.01","3.02","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 1.01, 3.01, 9.01","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-025244","json":"https://secwatch.observer/filing/0001493152-26-025244.json","markdown":"https://secwatch.observer/filing/0001493152-26-025244.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2030954/000149315226025244/0001493152-26-025244-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2030954/000149315226025244/form8-k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"May 20, 2026, the Company received written notice (the \"Notice\") from the Listing Qualifications Department of the Nasdaq notifying the Company that it is not in compliance with the minimum Market Value of Listed Securit","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1997296/000106299326002900/0001062993-26-002900-index.htm","comparable_excerpt":"May 26, 2026, the Company received a deficiency letter from the Listing Qualifications Department (the “ Staff ”)\nof The Nasdaq Stock Market LLC (“ Nasdaq ”), notifying the Company that it is not in compliance with Nasda","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2030954/000149315226025244/0001493152-26-025244-index.htm"}},{"accession":"0001213900-26-055912","ticker":"ISPC","company_name":"iSpecimen Inc.","filed_at":"2026-05-13T21:00:25+00:00","headline":"iSpecimen prices $2.5M private placement at $5.12/share; regains Nasdaq minimum bid price compliance","event_type":"other_material","sec_items":["1.01","3.01","3.02","7.01","8.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 1.01, 3.01, 9.01","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-055912","json":"https://secwatch.observer/filing/0001213900-26-055912.json","markdown":"https://secwatch.observer/filing/0001213900-26-055912.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1558569/000121390026055912/0001213900-26-055912-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1558569/000121390026055912/ea0290143-8k_ispecimen.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"May 20, 2026, the Company received written notice (the \"Notice\") from the Listing Qualifications Department of the Nasdaq notifying the Company that it is not in compliance with the minimum Market Value of Listed Securit","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1997296/000106299326002900/0001062993-26-002900-index.htm","comparable_excerpt":"minimum $1.00 per share required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Minimum\nBid Price Requirement”) for the prior 30 consecutive business days. On May 12, 2026","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1558569/000121390026055912/0001213900-26-055912-index.htm"}},{"accession":"0001829126-26-004960","ticker":"PMI","company_name":"Picard Medical, Inc.","filed_at":"2026-05-11T21:08:14+00:00","headline":"Picard Medical raises $5M in public offering, receives NYSE American delisting notice for low equity","event_type":"other_material","sec_items":["1.01","3.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 1.01, 3.01, 9.01","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-004960","json":"https://secwatch.observer/filing/0001829126-26-004960.json","markdown":"https://secwatch.observer/filing/0001829126-26-004960.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004960/0001829126-26-004960-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004960/picardmedical_8k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"May 20, 2026, the Company received written notice (the \"Notice\") from the Listing Qualifications Department of the Nasdaq notifying the Company that it is not in compliance with the minimum Market Value of Listed Securit","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1997296/000106299326002900/0001062993-26-002900-index.htm","comparable_excerpt":"May 8, 2026, the Company received a written notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) indicating that the Company is not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(ii) of the NYSE American Company Guide (the “Company Guide”) requiring a company to have stockholders’ equity of at least $4.0 million if it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. The Notice states that the Company reported a stockholders’ equity of approximately $3.8 million as of","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004960/0001829126-26-004960-index.htm"}},{"accession":"0001731122-26-000668","ticker":"SBEV","company_name":"SPLASH BEVERAGE GROUP, INC.","filed_at":"2026-05-05T23:59:59+00:00","headline":"Splash Beverage receives NYSE delisting notice; shareholders' equity negative $15.3M","event_type":"regulatory","sec_items":["1.01","1.02","3.01","3.02","5.03","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 1.01, 3.01, 9.01","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-26-000668","json":"https://secwatch.observer/filing/0001731122-26-000668.json","markdown":"https://secwatch.observer/filing/0001731122-26-000668.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226000668/0001731122-26-000668-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226000668/e7604_8-k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"May 20, 2026, the Company received written notice (the \"Notice\") from the Listing Qualifications Department of the Nasdaq notifying the Company that it is not in compliance with the minimum Market Value of Listed Securit","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1997296/000106299326002900/0001062993-26-002900-index.htm","comparable_excerpt":"April 29, 2026, the Company received notice from NYSE Regulation (the “NYSE”)\nthat the Company is not in compliance with the shareholders’ equity requirement of $6 million as of December 31, 2025 as outlined\nin Section 1","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226000668/0001731122-26-000668-index.htm"}},{"accession":"0001731122-26-000653","ticker":"LNAI","company_name":"Lunai Bioworks Inc.","filed_at":"2026-05-01T23:59:59+00:00","headline":"Lunai Bioworks completes merger to acquire CNS patent portfolio; issues $20M Series B Preferred Stock","event_type":"m_and_a","sec_items":["1.01","2.01","9.01","3.01","3.02","3.03","5.03"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 1.01, 3.01, 9.01","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-26-000653","json":"https://secwatch.observer/filing/0001731122-26-000653.json","markdown":"https://secwatch.observer/filing/0001731122-26-000653.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527728/000173112226000653/0001731122-26-000653-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527728/000173112226000653/e7595_8k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"May 20, 2026, the Company received written notice (the \"Notice\") from the Listing Qualifications Department of the Nasdaq notifying the Company that it is not in compliance with the minimum Market Value of Listed Securit","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1997296/000106299326002900/0001062993-26-002900-index.htm","comparable_excerpt":"April 20, 2026, the Company received notice from\nthe Panel (in the “Decision”) that it had until April 27, 2026, to regain compliance with the $2.5 million equity requirement\nunder Nasdaq Listing Rule 5550(b)(1)\n (the “S","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112226000653/0001731122-26-000653-index.htm"}},{"accession":"0001880613-26-000050","ticker":"DRCT","company_name":"Direct Digital Holdings, Inc.","filed_at":"2026-04-28T23:59:59+00:00","headline":"DRCT enters $50M equity line with Roth, terminates New Circle ELOC, receives Nasdaq delisting notice","event_type":"other_material","sec_items":["1.01","1.02","3.01","3.03","5.03","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 1.01, 3.01, 9.01","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001880613-26-000050","json":"https://secwatch.observer/filing/0001880613-26-000050.json","markdown":"https://secwatch.observer/filing/0001880613-26-000050.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1880613/000188061326000050/0001880613-26-000050-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1880613/000188061326000050/drct-20260423.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"May 20, 2026, the Company received written notice (the \"Notice\") from the Listing Qualifications Department of the Nasdaq notifying the Company that it is not in compliance with the minimum Market Value of Listed Securit","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1997296/000106299326002900/0001062993-26-002900-index.htm","comparable_excerpt":"April 23, 2026, the Company received an Additional Staff Delisting Determination Letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”), notifying the Company that it is not in comp","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1880613/000188061326000050/0001880613-26-000050-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}